Entact Bio Revenue and Competitors
Estimated Revenue & Valuation
- Entact Bio's estimated annual revenue is currently $4M per year.
- Entact Bio's estimated revenue per employee is $77,500
- Entact Bio's total funding is $127M.
Employee Data
- Entact Bio has 51 Employees.
- Entact Bio grew their employee count by 6% last year.
Entact Bio's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Scientific Officer | Reveal Email/Phone |
3 | SVP, Biological Sciences | Reveal Email/Phone |
4 | SVP Corporate Development and Strategy | Reveal Email/Phone |
5 | SVP, Corporate Development & Strategy | Reveal Email/Phone |
6 | Head Operations | Reveal Email/Phone |
7 | SVP, Molecular Discovery | Reveal Email/Phone |
8 | Executive Director, Molecular Discovery | Reveal Email/Phone |
9 | Director, Data Science | Reveal Email/Phone |
10 | Director | Reveal Email/Phone |
Entact Bio Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $12.7M | 82 | -45% | $107.3M | N/A |
#2 | $0.2M | 1 | -50% | N/A | N/A |
#3 | $6.2M | 40 | 21% | N/A | N/A |
#4 | $42.2M | 218 | 4% | $165M | N/A |
#5 | $14.6M | 94 | -37% | $312.8M | N/A |
#6 | $0.3M | 2 | -67% | N/A | N/A |
#7 | $235M | 366 | -5% | $340.9M | N/A |
#8 | $56M | 289 | -7% | $7.6M | N/A |
#9 | $4.7M | 61 | 36% | N/A | N/A |
#10 | $2M | 13 | 8% | N/A | N/A |
What Is Entact Bio?
Entact Bio is a preclinical stage biotechnology company developing a new class of drugs that enhance the function of beneficial proteins. Launched by a founding team deeply rooted in deubiquitinase (DUB) biochemistry, chemical biology, disease biology, and small-molecule drug development, Entact has designed its proprietary Encompass™ platform to create enhancement-targeting chimeric (ENTAC™) medicines. ENTACs harness the ability of DUBs to regulate proteins. By leveraging this natural cellular mechanism to enhance protein function, Entact is expanding the universe of treatable diseases.
keywords:N/A$127M
Total Funding
51
Number of Employees
$4M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $11.7M | 51 | 11% | N/A |
#2 | $22.4M | 52 | 41% | N/A |
#3 | $13.6M | 52 | 0% | N/A |
#4 | $10.9M | 54 | -60% | N/A |
#5 | $13.6M | 54 | -25% | N/A |